Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium

Trial Profile

Rivaroxaban Versus Warfarin in the Evaluation of Progression of Coronary Calcium

Active, no longer recruiting
Phase of Trial: Phase IV

Latest Information Update: 12 Mar 2018

At a glance

  • Drugs Rivaroxaban (Primary) ; Warfarin (Primary)
  • Indications Atherosclerosis
  • Focus Therapeutic Use
  • Most Recent Events

    • 12 Mar 2018 Status changed to active, no longer recruiting as per result presented at the 67th Annual Scientific Session of the American College of Cardiology
    • 12 Mar 2018 Results presented at the 67th Annual Scientific Session of the American College of Cardiology
    • 29 Jun 2017 Planned End Date changed from 1 Jul 2017 to 1 Apr 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top